跳至主要内容
临床试验/NCT06378944
NCT06378944招募中不适用

Selective Sentinella Lymph Node Biopsy With Indocyanine Green in Patients With Breast.

Omphis Foundation1 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2024年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
15,000
试验地点
1
主要终点
Number of Sentinel lymph node detected. Scale of numbers

研究概览

简要总结

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

详细描述

In the operating room 1 ml of indocyaninge grenn will be injectec periareolar . After 5 minutes the lymph node will be detected and extracted. The comparison between the lymph nodes detected with Technetium 99 and indocyanine green will be analysed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
  • N0 patients or patients who have undergone target axillary detection with good response

排除标准

  • Lymphadenectomy

结局指标

主要结局

Number of Sentinel lymph node detected. Scale of numbers

时间窗: patients included from 1 January of 2024 til January 1 2029

Number of lymph node detected with Indocyanine green and number of lymph node detected iwth techetium 99. Scale of numbers

次要结局

  • Number of possitive lymph nodes(patients included from 1 January of 2024 til January 1 2029)
  • surgery time in minutes(patients included from 1 January of 2024 til January 1 2029)

研究者

发起方
Omphis Foundation
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sandra Lopez Gordo

Doctor and head of the department of breast cancer unit Sandra Lopez Gordo

Omphis Foundation

研究点 (1)

Loading locations...

相似试验